We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.91B
AUM Growth
+$262M
Cap. Flow
+$277M
Cap. Flow %
14.49%
Top 10 Hldgs %
19.73%
Holding
2,148
New
107
Increased
688
Reduced
402
Closed
78

Sector Composition

Rank Sector Weight
1 Technology 6.51%
2 Healthcare 5.03%
3 Financials 4.9%
4 Industrials 3.29%
5 Consumer Discretionary 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
501
Strategy Inc
MSTR
$35.9B
$404K 0.02%
11,790
-230
-2% -$6.97K
PFN
502
PIMCO Income Strategy Fund II
PFN
$697M
$400K 0.02%
55,414
+32,076
+137% +$227K
AXP icon
503
American Express
AXP
$236B
$399K 0.02%
2,292
-2,354
-51% -$380K
FMHI icon
504
First Trust Municipal High Income ETF
FMHI
$999M
$397K 0.02%
8,436
+2,768
+49% +$130K
EXPE icon
505
Expedia Group
EXPE
$38.5B
$397K 0.02%
3,627
-619
-15% -$60.7K
XMMO icon
506
Invesco S&P MidCap Momentum ETF
XMMO
$7.4B
$397K 0.02%
4,987
+509
+11% +$38.4K
CLX icon
507
Clorox
CLX
$12.8B
$393K 0.02%
2,469
+186
+8% +$30K
IYG icon
508
iShares US Financial Services ETF
IYG
$2.22B
$392K 0.02%
7,443
GL icon
509
Globe Life
GL
$14.3B
$392K 0.02%
3,574
-73
-2% -$7.84K
TTD icon
510
Trade Desk
TTD
$8.9B
$391K 0.02%
5,062
+1,450
+40% +$98.1K
IVT icon
511
InvenTrust Properties
IVT
$2.61B
$390K 0.02%
16,859
-1,274
-7% -$28.7K
GRMN
512
Garmin
GRMN
$58.4B
$388K 0.02%
3,720
+701
+23% +$71.6K
TFC icon
513
Truist Financial
TFC
$64.6B
$386K 0.02%
12,724
+106
+0.8% +$3.29K
TEVA icon
514
Teva Pharmaceuticals
TEVA
$40.4B
$386K 0.02%
51,282
+200
+0.4% +$1.62K
GVA icon
515
Granite Construction
GVA
$5.4B
$386K 0.02%
9,699
-1,202
-11% -$46K
USB icon
516
US Bancorp
USB
$100B
$385K 0.02%
11,650
+1,913
+20% +$61.8K
SHEL icon
517
Shell
SHEL
$243B
$384K 0.02%
6,360
+2,968
+88% +$178K
FALN icon
518
iShares Fallen Angels USD Bond ETF
FALN
$1.62B
$383K 0.02%
15,115
+10,012
+196% +$250K
SCHA icon
519
Schwab U.S Small- Cap ETF
SCHA
$23B
$383K 0.02%
5,454
+1,376
+34% +$28.7K
VSGX icon
520
Vanguard ESG International Stock ETF
VSGX
$6.69B
$383K 0.02%
7,214
-208
-3% -$11K
VEU icon
521
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$383K 0.02%
7,032
+515
+8% +$27.9K
PBTP icon
522
Invesco 0-5 Yr US TIPS ETF
PBTP
$116M
$382K 0.02%
15,602
+1,263
+9% +$31.4K
IUSG icon
523
iShares Core S&P US Growth ETF
IUSG
$33.4B
$382K 0.02%
3,911
CCJ icon
524
Cameco
CCJ
$41.1B
$379K 0.02%
12,100
-1,100
-8% -$30.9K
SUB icon
525
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$378K 0.02%
3,636
+544
+18% +$56.6K

Similar funds

Geneos Wealth Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geneos Wealth Management held 2,148 positions worth $1.91B, up 16% from $1.65B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management deployed $277M of net new capital in Q2 2023, opening 107 new positions and adding to 688 existing holdings. Its largest new stake was Pultegroup: 23,752 shares worth $1.85M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Cardinal Health, an estimated $5.28M trimmed.

  • Geneos Wealth Management's largest Q2 2023 buy was Pultegroup: 23,752 shares worth $1.85M.
  • Geneos Wealth Management added most to Apple in Q2 2023, an estimated $61.1M increase.
  • Geneos Wealth Management's biggest Q2 2023 reduction was Cardinal Health, cutting an estimated $5.28M.
  • Geneos Wealth Management fully exited State Street SPDR S&P Telecom ETF in Q2 2023, selling an estimated $958K.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $1.91B portfolio in Q2 2023.
  • Geneos Wealth Management opened 107 new positions and closed 78 in Q2 2023.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $1.91B.

Based on Geneos Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.